Latest Software Platforms News

Locate Technologies’ Q4 FY26 update highlights a 54% surge in Locate2u revenue to NZ$1.20 million, driving normalised EBITDA into positive territory. AI integration accelerated product development and customer onboarding, while capital moves included a share buyback and royalty conversion.

Monvia Limited, an Australian SaaS provider for life insurers, is seeking to raise $17.5 million via an IPO on the ASX. The funds will support redemption of preference shares and fuel growth in existing and new markets.

Orcoda Limited has lifted its Annual Recurring Revenue by 23% year-on-year to $6.2 million, with a new multi-year Wagner Corporation contract pushing total ARR to $14.2 million as it enters FY27.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.

Livestock Improvement Corporation reported a 6.7% revenue increase to NZD 314.8 million for FY26, but net profit after tax fell 30.4% to NZD 21.3 million due to significant technology investments. The co-operative declared a 12.26 cent dividend, maintaining strong underlying earnings and a debt-free balance sheet.

Bridge SaaS Limited has exited its non-core investment in Brightside Disability Support, recouping its initial outlay and sharpening its focus on AI-driven disability services and robotics innovation.

Spacetalk has inked a strategic MVNO deal with TPG Telecom, aiming to improve mobile service economics and accelerate subscriber growth as it shifts towards a software-led business model.

Bravura Solutions plans to list on the London Stock Exchange's AIM market by late July 2026, aiming to tap into UK and European institutional investors while maintaining its ASX primary listing.

BCAL Diagnostics has locked in an additional $4.9 million under its existing convertible note facility alongside a $1.4 million R&D tax offset tranche, reinforcing its funding runway into FY2027 for early cancer detection test development.

Echo IQ has locked in a binding Heads of Agreement with Pro Medicus for a strategic A$20 million investment and a US commercial partnership to accelerate adoption of its AI-powered cardiac diagnostic platform.

CONNEQT Health has lodged an FDA Pre-Submission for SphygmoCor Cloud, aiming to shift its arterial health analytics from hardware to a scalable software platform with broad commercial potential.

NoviqTech Limited has clarified that its planned divestment of Non-Coralia assets was not foreseen during its Coralia acquisition and reflects a strategic pivot to biochar carbon removal, with leadership changes aligned to this refocus.